TGTX insider transactions
TG Therapeutics Inc. (TGTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for TGTX
- Director Charney Laurence N gifted 43,197 shares, decreasing direct ownership by 19% to 179,690 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- CEO Weiss Michael S was granted 622,000 shares, increasing direct ownership by 7% to 9,778,086 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- CFO Power Sean A was granted 90,000 shares, increasing direct ownership by 13% to 798,111 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Echelard Yann sold $162,850 worth of shares (5,000 units at $32.57), decreasing direct ownership by 2% to 223,816 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- CEO Weiss Michael S gifted 4,668,843 shares, decreasing direct ownership by 34% to 9,156,086 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Lonial Sagar sold $672,268 worth of shares (20,852 units at $32.24), decreasing direct ownership by 18% to 94,061 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Echelard Yann was granted 14,718 shares and sold $369,400 worth of shares (10,000 units at $36.94), increasing direct ownership by 2% to 228,816 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Charney Laurence N was granted 21,408 shares, increasing direct ownership by 11% to 222,887 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Hoberman Kenneth was granted 14,718 shares, increasing direct ownership by 6% to 279,653 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Hume Daniel was granted 14,718 shares, increasing direct ownership by 8% to 192,748 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Lonial Sagar was granted 14,718 shares, increasing direct ownership by 15% to 114,913 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Hume Daniel gifted 62,459 shares, decreasing direct ownership by 26% to 178,030 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Charney Laurence N gifted 6,000 shares, decreasing direct ownership by 3% to 201,479 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- CEO Weiss Michael S was granted 750,000 shares, increasing direct ownership by 6% to 13,824,929 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- CFO Power Sean A was granted 87,500 shares, increasing direct ownership by 14% to 708,111 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- CFO Power Sean A sold $629,382 worth of shares (21,358 units at $29.47), decreasing direct ownership by 3% to 660,611 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Lonial Sagar sold $152,200 worth of shares (5,000 units at $30.44), decreasing direct ownership by 5% to 100,195 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Charney Laurence N sold $754,875 worth of shares (25,000 units at $30.20) and gifted 5,000 shares, decreasing direct ownership by 13% to 207,479 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Echelard Yann sold $489,600 worth of shares (20,000 units at $24.48), decreasing direct ownership by 8% to 224,098 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Lonial Sagar sold $432,889 worth of shares (25,933 units at $16.69) and was granted 22,250 shares, decreasing direct ownership by 3% to 105,195 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Hume Daniel was granted 22,250 shares, increasing direct ownership by 10% to 240,489 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Hoberman Kenneth was granted 22,250 shares, increasing direct ownership by 9% to 264,935 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Echelard Yann was granted 22,250 shares, increasing direct ownership by 10% to 244,098 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Director Charney Laurence N was granted 22,250 shares, increasing direct ownership by 10% to 237,479 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Lonial Sagar sold $79,675 worth of shares (5,000 units at $15.94), decreasing direct ownership by 4% to 108,878 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Charney Laurence N sold $351,340 worth of shares (22,000 units at $15.97), decreasing direct ownership by 9% to 215,229 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Power Sean A decreased direct ownership by 6% to 641,969 units (SEC Form 5)5 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Charney Laurence N sold $333,025 worth of shares (17,500 units at $19.03), decreasing direct ownership by 7% to 237,229 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Weiss Michael S was granted 1,001,908 shares, increasing direct ownership by 8% to 13,074,929 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Power Sean A was granted 75,000 shares and sold $809,431 worth of shares (47,867 units at $16.91), increasing direct ownership by 4% to 681,969 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Hume Daniel was granted 20,000 shares, increasing direct ownership by 10% to 218,239 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Echelard Yann was granted 20,000 shares, increasing direct ownership by 10% to 221,848 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Charney Laurence N was granted 20,000 shares, increasing direct ownership by 9% to 254,729 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Lonial Sagar gave a grant of 20,000 shares, decreasing direct ownership by 15% to 113,878 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- Hoberman Kenneth was granted 20,000 shares, increasing direct ownership by 9% to 242,685 units (SEC Form 4)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Weiss Michael S bought $1,013,000 worth of shares (100,000 units at $10.13), increasing direct ownership by 0.84% to 12,073,021 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4 filed by Lonial Sagar4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4 filed by Power Sean A4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Power Sean A was granted 85,000 shares, increasing direct ownership by 13% to 728,483 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Weiss Michael S was granted 985,000 shares, increasing direct ownership by 9% to 11,973,021 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Echelard Yann bought $95,760 worth of shares (9,000 units at $10.64), increasing direct ownership by 5% to 201,848 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Charney Laurence N sold $333,000 worth of shares (30,000 units at $11.10), decreasing direct ownership by 11% to 234,729 units (for withholding tax)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4 filed by Weiss Michael S4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Power Sean A was granted 75,000 shares, increasing direct ownership by 13% to 643,483 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Lonial Sagar was granted 43,732 shares, increasing direct ownership by 51% to 128,732 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Hume Daniel was granted 43,732 shares, increasing direct ownership by 28% to 198,239 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Hoberman Kenneth was granted 43,732 shares, increasing direct ownership by 24% to 222,685 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Echelard Yann was granted 43,732 shares, increasing direct ownership by 29% to 192,848 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Charney Laurence N was granted 43,732 shares, increasing direct ownership by 20% to 264,729 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Power Sean A sold $1,622,737 worth of shares (84,965 units at $19.10), decreasing direct ownership by 13% to 568,483 units to cover taxes4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Weiss Michael S gifted 712,000 shares, was granted 56,394 shares and sold $1,282,527 worth of shares (68,220 units at $18.80), decreasing direct ownership by 22% to 10,988,021 units (withholding tax)4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: WEISS MICHAEL S was granted 1,080,770 units of COMMON STOCK, increasing direct ownership by 8% to 14,148,852 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Power Sean A was granted 25,000 units of COMMON STOCK, increasing direct ownership by 4% to 653,448 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Lonial Sagar was granted 20,000 units of COMMON STOCK, increasing direct ownership by 31% to 85,000 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: HUME DANIEL was granted 20,000 units of COMMON STOCK, increasing direct ownership by 15% to 154,507 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Hoberman Kenneth was granted 20,000 units of COMMON STOCK, increasing direct ownership by 13% to 178,953 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Echelard Yann was granted 20,000 units of COMMON STOCK, increasing direct ownership by 15% to 149,116 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 4: Charney Laurence N was granted 60,000 units of COMMON STOCK, increasing direct ownership by 37% to 220,997 units4 - TG THERAPEUTICS, INC. (0001001316) (Issuer)
- SEC Form 5: A Sean Power gifted 132,000 units of COMMON STOCK, decreasing ownership by 17% to 629,438 units5 - TG THERAPEUTICS, INC. (0001001316) (Issuer)